PubMed Health⌕ Search

Biomedical subjects

A Sipahi

Publications and source records attributed to A Sipahi.

6 recordsLinked to original sources
PubMedDate not supplied

[Physiopathology of the short bowel: apropos of 2 cases].

A 54 years old white woman and a 38 years old white man with short-bowel disease are reported. Both of them were submitted to surgical procedures for urinary oxalate calculi. They presented malabsorption syndrome with steatorrhea and severe malnutrition. The patients received parenteral nutrition. The woman had also cholelithiasis and acute pancreatitis. The clinical and laboratory data are presented and the pathophysiology of short-bowel disease with emphasis on bile salts depletion, the effect of bile salts on colon oxalate absorption, and intestinal loss of water is commented. The management of short-bowel disease and the use of cholesteramine and the supplementary diet is discussed.

Adult↗
PubMedDate not supplied

[D-xilose test during 3 hours. Dose standardization ].

A study is made of the behavior of urinary excretion of D-xilose three and five hours after the ingestion of 5 and 25 g of the substance. Twenty individuals were studied, 13 as control having no intestinal mucosa disease and 7 with steatorrhea and enteric lesions histologically confirmed. An analysis of the results revealed that with both doses it is possible to reduce the test time from five to three hours and thus differentiate the controls from the group of patients. No secondary side effects were observed with 5 g, which were present in 30% (6 cases) of the patients with doses of 25 g. In view of the results the use of 5 g in the test is indicated in the 3 hour test. Under these conditions 95% (1, 645 D.P.) for the controls excreted less than 1, 030 g (21%) of the doses administered.

Adolescent↗
PubMedDate not supplied

Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.

The aim of this work was to evaluate and compare the effects of a low calorie diet (1026 kcal), simvastatin and ursodeoxycholic acid administration on biliary lipid secretion and cholic acid kinetics in dieting obese subjects. We studied 6 obese subjects before and after four weeks of a hypocaloric diet alone, after four weeks of diet plus ursodeoxycholic acid (900 mg/day) and after four weeks of diet plus simvastatin (40 mg/day), according to a Latin square design. The cholesterol saturation index was increased after diet alone, significantly reduced with diet plus ursodeoxycholic acid (p < 0.01), and unchanged during simvastatin administration. While the cholesterol output was reduced by all three regimens, diet plus ursodeoxycholic acid caused a significantly greater decrease than diet alone (p < 0.01). Cholic acid synthesis and bile acid secretion were decreased by diet and diet plus simvastatin (p < 0.05), but neither was affected by ursodeoxycholic acid. For cholic acid, all three treatments, but especially diet alone and diet plus simvastatin (p < 0.05), reduced the pool size; all three regimens also increased the turnover rate, but this was significant only for ursodeoxycholic acid (p < 0.01). Our study shows that, in obese patients, a hypocaloric diet reduces cholesterol-holding biliary lipid output and consequently increases the cholesterol saturation index. The addition of simvastatin to a hypocaloric dietary regimen reduces cholesterol secretion, but without variation in bile acid and phospholipid output thus the cholesterol saturation index remains unchanged. When ursodeoxycholic acid is added to the dietary regimen, it reduces cholesterol secretion, while maintaining bile acid output and, thus, lowers the cholesterol saturation index. Unlike simvastatin, ursodeoxycholic acid prevents the drop in cholic acid synthesis induced by a low calorie diet.

Adult↗